Paul E. Verweij
Researcher Next ID · RN-003362
Researcher · Medicine
Nijmegen, Netherlands
- Works count
- 742
- Citation count
- 50,850
- H-index
- 112
- i10-index
- 482
Research interests
Publications
Tackling the emerging threat of antifungal resistance to human health
Nature Reviews Microbiology · 2022 · https://doi.org/10.1038/s41579-022-00720-1
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
The Lancet Infectious Diseases · 2020 · https://doi.org/10.1016/s1473-3099(20)30847-1
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Clinical Infectious Diseases · 2019 · https://doi.org/10.1093/cid/ciz1008
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection · 2018 · https://doi.org/10.1016/j.cmi.2018.01.002
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12039
Current projects
No projects listed.